Streptococcus pneumoniae
A Gram-positive diplococcus causing pneumonia and other invasive diseases.
Streptococcus pneumoniae, also known as pneumococcus, is a Gram-positive, spherical bacterium that is a significant human pathogen. It was recognized as a major cause of pneumonia in the late 19th century and is the subject of many humoral immunity studies. The organism typically resides asymptomatically in healthy carriers, colonizing the respiratory tract, but can become pathogenic in individuals with weaker immune systems, such as the elderly and young children.
- type
- Bacterium
- field
- Microbiology, Infectious disease
- known_for
- Major cause of pneumonia, meningitis, and sepsis; central role in demonstrating that genetic material consists of DNA
- genome_size
- 2.0 to 2.1 million base pairs
Lore & Background
Army physician George Sternberg and French chemist Louis Pasteur.
Reader's Guide
Streptococcus pneumoniae is a leading cause of community-acquired pneumonia and meningitis in children and the elderly, as well as sepsis in those infected with HIV. It causes a wide range of invasive pneumococcal diseases, including bronchitis, otitis media, and endocarditis. Its genome contains between 2.0 and 2.1 million base pairs, and natural transformation—a process requiring at least 23 genes—allows it to take up exogenous DNA, which may aid in repairing oxidative DNA damage from host immune responses. The organism's ability to undergo phase variation between transparent and opaque colony phenotypes helps it survive in different human body systems. Its historical role in demonstrating that DNA is the genetic material remains a landmark in molecular biology.
Did You Know?
- Streptococcus pneumoniae cells are usually found in pairs (diplococci) and do not form spores.
- The organism can be differentiated from viridans streptococci using an optochin test, as S. pneumoniae is optochin-sensitive.
History & Discovery
Perhaps its most consequential legacy, however, lies in the history of genetics. Fourteen years later, Oswald Avery, Colin MacLeod, and Maclyn McCarty identified the transforming factor as DNA rather than protein, a finding that launched the molecular era of genetics.
Capsule & Virulence Machinery
The defining weapon of Streptococcus pneumoniae is its polysaccharide capsule, a viscous outermost layer anchored to the peptidoglycan cell wall. This capsule is assembled from high-molecular-weight polymers of repeating oligosaccharide units covalently bonded to the cell surface, and it functions as a formidable shield against the host immune system. By physically blocking granulocytes from reaching the cell wall, the capsule effectively inhibits phagocytosis, granting the bacterium a critical survival advantage. Beyond the capsule, the organism deploys additional virulence tools including pneumolysin, various adhesins, and immunogenic cell wall components. Together, these factors determine whether a colonizing strain remains harmless in the respiratory tract or invades deeper tissues to cause serious disease.
Clinical Impact & Disease Spectrum
Although Streptococcus pneumoniae routinely colonizes the nasal cavity, sinuses, and respiratory tract of healthy carriers without provoking symptoms, it becomes a serious threat when the host's immune defenses are weakened, particularly in the elderly and young children. Transmission occurs through direct person-to-person contact via respiratory droplets, and auto-inoculation from the upper airways can seed infection at distant sites. The bacterium is the principal cause of community-acquired pneumonia and meningitis in children and older adults, and it drives sepsis in individuals living with HIV. Its disease spectrum extends far beyond the lungs: invasive pneumococcal infections encompass bronchitis, acute sinusitis, otitis media, conjunctivitis, osteomyelitis, septic arthritis, endocarditis, peritonitis, pericarditis, cellulitis, and brain abscess. It can even cause neonatal infections. The sheer breadth of this clinical picture underscores why pneumococcus has long been a central subject of humoral immunity research.
Genetics & Natural Transformation
Genetic variation between strains can reach ten percent, and the genome harbors a diverse arsenal of antimicrobial peptides, including eleven distinct lantibiotics. One of the organism's most remarkable capabilities is natural transformation — the uptake and recombination of exogenous DNA from the surrounding medium. This process demands a specialized physiological state called competence, governed by at least 23 genes, and is triggered by DNA-damaging agents such as fluoroquinolone antibiotics and topoisomerase inhibitors. Research by Michod and colleagues suggests that competence induction is an adaptive response to oxidative stress, boosting RecA-mediated recombinational repair. Because host granulocytes generate a potentially lethal oxidative burst during infection, the ability to repair this damage likely enhances virulence. Li and others confirmed that nasal colonization fitness and lung infectivity depend on an intact competence system.
Frequently Asked Questions
What diseases does Streptococcus pneumoniae cause?
This diplococcus is a leading cause of pneumonia, bacterial meningitis, and bloodstream infections (sepsis), particularly in vulnerable groups. It tends to shift from a harmless colonizer to a pathogen in people with weakened immunity, such as the elderly and young children.
How does Streptococcus pneumoniae's story end?
In healthy carriers the bacterium simply persists in the nasopharynx without triggering illness. When it does invade deeper tissues, the host's antibody-mediated immune response—directed largely against its polysaccharide capsule—usually clears the infection, though severe cases in immunocompromised individuals can prove fatal.
Why is Streptococcus pneumoniae important in science?
Beyond its clinical impact, pneumococcus was central to the landmark experiments that demonstrated DNA, rather than protein, carries genetic information. It also remains a go-to model for studying humoral immunity, capsular variation, and bacterial pathogenesis.
More in Microbial Pathogens 1-20
Spotted an error? Know more?
This is a living reference — every entry is fact-audited, and reader corrections feed straight into our audit queue. Suggest an edit · See this site's audit record
